Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05312164 · ClinicalTrials.gov registry record

Physio-Anatomy Clinical Data Collection Study

A clinical trial of Coronary Stenosis, sponsored by Gentuity.

Recruiting
Registry status
150
Enrollment target
6
Study locations

NCT05312164 is a study of Coronary Stenosis that is actively recruiting participants, run by Gentuity. The registered enrollment target is 150 participants, below the 1,332-participant average among 5 other Coronary Stenosis trials with a reported enrollment target (89% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05312164, a study of Coronary Stenosis, is actively recruiting participants, sponsored by Gentuity.

RECRUITING
Registry status
150 participants
Enrollment target
6
Study locations

Study Summary

This is an on-label clinical study design intended for the collection of three different types of interventional procedural data using FDA-cleared cardiac catheterization technologies and drugs, each used according to its product labeling and standard practice of medicine.

Conditions Studied

Interventions

  • DEVICE HF-OCT Imaging
  • DEVICE FFR Pressure Wire
  • DEVICE Angiography

Study Locations (6)

California

  • Veteran's Administration Palo Alto - Palo Alto

Florida

  • Tampa General Hospital - Tampa

Georgia

  • Atlanta VA Medical Center - Decatur

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Minnesota

  • Minneapolis VA Medical Center - Minneapolis

Ohio

  • The Christ Hospital - Cincinnati

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-03-14
Est. Completion 2025-12-31

Sponsor

Gentuity

3 total trials

What the Registry Record Tells You About NCT05312164

The ClinicalTrials.gov registry entry for NCT05312164 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,332-participant average among 5 other Coronary Stenosis trials with a reported enrollment target (89% lower). The listed sponsor is Gentuity, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Stenosis appearing as the primary indexed condition, and to 3 interventions - of which HF-OCT Imaging is the first listed.

NCT05312164 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT05312164 about?

NCT05312164 is a clinical study titled "Physio-Anatomy Clinical Data Collection Study". This is an on-label clinical study design intended for the collection of three different types of interventional procedural data using FDA-cleared cardiac catheterization technologies and drugs, each used according to its product labeling and standard practice of medicine.

What is the current status of trial NCT05312164?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2022-03-14. Estimated completion is 2025-12-31.

What conditions does trial NCT05312164 study?

This clinical trial studies the following conditions: Coronary Stenosis.

What interventions are being tested in trial NCT05312164?

The interventions under investigation include: HF-OCT Imaging (DEVICE), FFR Pressure Wire (DEVICE), Angiography (DEVICE).

Who is sponsoring clinical trial NCT05312164?

This trial is sponsored by Gentuity, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05312164 being conducted?

This trial has 6 study locations across California, Florida, Georgia, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.